HIV / AIDS in the News

Wesley Sundquist ’81 named to TIME 100 Most Influential People of 2025 – News - Carleton College

 

Delray Beach man accused of selling fake HIV medicine nationwide - WTVX

 

Delray Beach man accused of selling fake HIV medicine nationwide - WPEC

 

I’m a doctor specialising in HIV – we should be very afraid of cuts to Aids funding - The Independent

 

What is drug resistance and why is it a problem? - The Independent

 

WHO warns Trump cuts put millions of HIV patients at risk - The Independent

 

Trump funding cuts harming HIV patients, WHO says - The Independent

 

Gilead leans on HIV drugs as oncology sales slow - BioPharma Dive

 

Gilead, not sweating looming tariff threats, stands by long-acting PrEP launch - Fierce Pharma

 

Gilead Sciences Q1 Earnings Review: HIV Division Masks Underperformance (GILD) - Seeking Alpha

 

24th HIV case detected in Penobscot County outbreak - Bangor Daily News

 

New couples-based intervention looks to improve HIV health outcomes in Malawi - UNC Gillings School of Global Public Health

 

Gilead’s PrEP Launch Full Speed Ahead Despite Macro Pressures on HIV Space - BioSpace

 

A ‘Miracle’ HIV Drug May Not Reach the Women Who Need It Most - Bloomberg.com

 

Revenues flat at Gilead as HIV strength offsets oncology struggle - The Pharma Letter

 

Gilead's growth plans hinge on lenacapavir after revenue miss - FirstWord Pharma

 

Rockdale County man faces felony murder charge; accused of infecting wife with AIDS - FOX 5 Atlanta

 

Supreme Court Weighs Case That Could Undermine HIV Prevention, Cancer Screenings - OutSmart Magazine

 

Watching Aid Cuts as a Medical Worker in Malawi - Sojourners

 

Gilead posts profit, says HIV prevention drug on track for mid-June - Reuters

 

Watching Aid Cuts as a Medical Worker in Malawi - Sojourners

 

Demonstrators stage ‘die-in’ at HHS to protest cuts to HIV programs - The Hill

 

Gilead Sciences in charts: Revenue from HIV product sales grows most among segments in Q1 (GILD:NASDAQ) - Seeking Alpha

 

Gilead slips after sales miss - Sherwood News

 

Gilead's strong HIV business balances out low Covid and cancer drug sales - Endpoints News

 

Simmons: New PrEP HIV prevention initiative supports healthy communities - Illinois Senate Democratic Caucus

 

Dining Out for Life fundraiser supports HIV-AIDS prevention and treatment - WCIV

 

Gilead Q125 slides: Base business grows 4% YoY, HIV franchise leads performance - Investing.com

 

Gilead's HIV Sales Shine While Overall Growth Stagnates - Finimize

 

Positive Human Immunodeficiency Virus (HIV) Test Following Influenza Vaccination: A Case Report - Cureus